1.
Scutellarin Protects Retinal Ganglion Cells in Glaucoma by Targeting the Hsp90aa1-MAPK Pathway to Inhibit Apoptosis.
Su Jing-Zhi, Wang Jing, Gao Zhao-Lin, Ding Lexi, Xia Xiao-Bo
Invest Ophthalmol Vis SciNov 20250 citationsBasic Science
Scutellarin protected retinal ganglion cells in a glaucoma model by inhibiting apoptosis via the Hsp90aa1-MAPK pathway, offering a potential neuroprotective treatment to prevent vision loss.